Harpoon Therapeutics, Inc.

NASDAQ:HARP

23.01 (USD) • At close March 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019201820172016
Operating Activities:
Net Income -67.731-116.721-49.908-55.572-27.366-16.83-11.406
Depreciation & Amortization 2.3572.192.0820.90.6440.3660.198
Deferred Income Tax 02.3690.491-0.541000.004
Stock Based Compensation 8.6369.4624.862.0710.6720.3670.099
Change In Working Capital -33.578-19.9133.42749.049-1.07617.5260.05
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 2.0470.542-1.228-1.7612.5550.8040.57
Other Working Capital -35.625-20.45234.65550.81-3.63116.722-0.52
Other Non Cash Items 1.1340.4560.4321.20200.2850.261
Operating Cash Flow -89.182-122.154-8.616-2.891-27.1261.714-10.794
Investing Activities:
Investments In Property Plant And Equipment -0.347-0.1-0.683-3.516-0.663-2.275-0.553
Acquisitions Net -89.737000000
Purchases Of Investments -24.426-151.965-202.182-141.816000
Sales Maturities Of Investments 114.51186.419139.23976.017000
Other Investing Activites 89.73700006.750
Investing Cash Flow 89.73734.354-63.626-69.315-0.6634.475-0.553
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 5.382110.3493.03270.64689.8280.0020
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.991.1741.6440.803-1.50222.2479.985
Financing Cash Flow 6.372111.5234.67671.44988.32622.2499.985
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 6.92723.723-67.566-0.75760.53728.438-1.362
Cash At End Of Period 52.28745.3621.63789.20389.9629.4230.985